Pathstone Holdings’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,118
Closed -$97.3K 2339
2024
Q4
$97.3K Sell
10,118
-39,144
-79% -$305K ﹤0.01% 2236
2024
Q3
$291K Sell
49,262
-32,470
-40% -$215K ﹤0.01% 1989
2024
Q2
$566K Sell
81,732
-21,024
-20% -$148K ﹤0.01% 1621
2024
Q1
$791K Buy
102,756
+64,958
+172% +$522K ﹤0.01% 1435
2023
Q4
$331K Buy
+37,798
New +$277K ﹤0.01% 1751

Other funds holding MDXG

Pathstone Holdings's MDXG Position: Q1 2025 in Review

Pathstone Holdings sold out of MiMedx Group (MDXG) in Q1 2025, closing a stake of 10,118 shares — an estimated $97.3K sold.

Pathstone Holdings first reported a position in MDXG in Q4 2023 and held it in 5 quarters. The position peaked at $791K in Q1 2024. 218 funds tracked by Wall St. Rank hold MDXG as of Q1 2025.

  • Pathstone Holdings reported no remaining MiMedx Group position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 10,118 MiMedx Group shares in Q1 2025, an estimated $97.3K.
  • Pathstone Holdings first reported a position in MiMedx Group in Q4 2023 and held it in 5 quarters.
  • Pathstone Holdings's MiMedx Group position peaked at $791K in Q1 2024.
  • 218 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.